About Biosense
Biosense is a company based in Mumbai (India) founded in 2008 by Darshan Hammanna Nayak was acquired by Tulip Diagnostics in November 2019. It operates as a HealthTech and Direct-to-Consumer (D2C). Biosense has raised $4.77 million across 17 funding rounds from investors including Prudent, Kae Capital and HHS. The company has 64 employees as of April 09, 2024. Biosense offers products and services including SYNC Glucometer, Uchek, and ToucHb. Biosense operates in a competitive market with competitors including Jana Care, i-SENS, Telcare, Beurer UK and EzeRx, among others.
- Headquarter Mumbai, India
- Employees 64 as on 09 Apr, 2024
- Founders Darshan Hammanna Nayak
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biosense Technologies Private Limited
- Date of Incorporation 05 Dec, 2008
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$7.34 M (USD)-39.29as on Mar 31, 2022
-
Net Profit
-$397.92 K (USD)52.94as on Mar 31, 2022
-
EBITDA
-$220.82 K (USD)-235.76as on Mar 31, 2022
-
Total Equity Funding
$4.77 M (USD)
in 17 rounds
-
Latest Funding Round
$1 M (USD), Seed
Apr 11, 2018
-
Investors
Prudent
& 25 more
-
Employee Count
64
as on Apr 09, 2024
-
Acquired by
Tulip Diagnostics
(Nov 15, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biosense
Biosense offers a comprehensive portfolio of products and services, including SYNC Glucometer, Uchek, and ToucHb.
A compact glucometer is designed for personal use.
A smartphone-based system is used for urine analysis.
A non-invasive device is used for anaemia screening.
Funding Insights of Biosense
Biosense has successfully raised a total of $4.77M across 17 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biosense
Biosense has secured backing from 26 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Prudent, Kae Capital and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in social impact sectors such as agriculture, healthcare, and education in India.
|
Locked | Locked | Locked | |
|
Sector agnostic startup incubator
|
Locked | Locked | Locked | |
|
Provider of impact investment firm based in Singapore focused on investing in startups and early-stage social businesses
|
Locked | Locked | Locked |
Investor details for Biosense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biosense
Investment portfolio details for Biosense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biosense
Detailed financials for Biosense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biosense Comparisons
Peer comparison for Biosense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biosense
Biosense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jana Care, i-SENS, Telcare, Beurer UK and EzeRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
|
| Locked | Locked | Locked |
Blood glucose monitoring systems and clinical chemistry analyzers are developed.
|
|
| Locked | Locked | Locked |
Diabetes is managed via cellular technology and social networking.
|
|
| Locked | Locked | Locked |
Manufactures health devices, beauty tools, wellbeing products, and medical aids for consumers worldwide.
|
|
| Locked | Locked | Locked |
Non-invasive IoT diagnostic devices are manufactured for accessible health screening.
|
|
| Locked | Locked | Locked |
Provides blood glucose monitoring systems and diabetes care solutions worldwide.
|
Detailed competitors of Biosense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biosense
Complete news archive for Biosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biosense
Biosense was founded in 2008.
Biosense is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Biosense is a funded company, having raised a total of $4.77M across 17 funding rounds to date.
As of Apr 09, 2024, the latest employee count at Biosense is 64.
Annual revenue of Biosense is $7.34M as on Mar 31, 2022.
Biosense is focused on creating technologically advanced, user-friendly medical devices for screening and managing health conditions. The company targets critical areas such as diabetes, anaemia, and malnutrition through products like SYNC Glucometer, Uchek, and ToucHb. Solutions are designed to reduce the burden on primary healthcare services while empowering users with real-time health management tools. Operations are centered in the healthcare sector, emphasizing diagnostic equipment for widespread conditions in India and beyond.
Biosense offers SYNC Glucometer, Uchek, and ToucHb.
Biosense has 26 investors. Key investors include Prudent, Kae Capital, HHS, Artha Venture Fund, and Tulip Diagnostics.
The valuation of Biosense is $5.65M as of Oct 2017.